Numeta G16e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numeta G16e is used as a component of parenteral nutrition regimens for patients with increased protein and amino acid requirements.

• Critical illness: helps meet heightened metabolic demand and supports tissue repair.
• Post‑operative recovery: provides essential amino acids for wound healing and recovery.
• Severe malnutrition: supplies necessary building blocks when oral intake is insufficient.
• Long‑term home parenteral nutrition: maintains nutritional status in patients dependent on intravenous feeding.
• Metabolic disorders: assists in correcting specific amino‑acid imbalances.
• Pre‑transplant conditioning: provides nutritional support before organ transplantation.

• Numeta G16e delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, support nitrogen balance, and act as precursors for neurotransmitters and metabolic intermediates, thereby helping to maintain cellular function and promote tissue repair during periods of catabolic stress.

Numeta G16e may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects

• Mild fever or chills during infusion.
• Transient increase in blood urea nitrogen.
• Slight elevation of liver enzymes.
• Local irritation at the catheter site.
• Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Severe hypersensitivity or anaphylaxis.
• Hyperammonemia leading to neurological changes.
• Metabolic acidosis.
• Significant electrolyte imbalance (e.g., hyperkalemia).
• Thrombophlebitis or catheter‑related bloodstream infection.

When using Numeta G16e, clinicians should assess patient-specific factors and monitor relevant parameters.

• Renal function: adjust infusion rate in patients with impaired kidney function.
• Hepatic function: monitor liver enzymes and ammonia levels.
• Electrolytes: check serum electrolytes regularly during therapy.
• Catheter care: maintain aseptic technique to prevent infection.
• Fluid balance: consider total fluid volume to avoid overload.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Numeta G16e can interact with other intravenous solutions and medications that affect nitrogen balance or electrolyte status.

Major Interactions (Avoid)

• High‑dose nitrogen‑containing drugs (e.g., certain chemotherapeutics) that may exacerbate hyperammonemia.
• Potassium‑rich solutions administered concurrently without monitoring.

Moderate Interactions (Monitor Closely)

• Diuretics that alter electrolyte balance.
• Insulin therapy, which can shift potassium intracellularly.
• Acid‑base altering agents (e.g., bicarbonate) that may affect amino‑acid metabolism.
• Anticoagulants, due to potential catheter‑related thrombosis risk.
• Other parenteral nutrition components that could lead to excess caloric load.